IVECO and Foton announce joint exploration into future synergies 4-06-2024, 16:00

eXp Realty Ignites Global Expansion: Türkiye, Peru, and Egypt Set To Join in 2025 29-10-2024, 00:00

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00